|4Jun 15, 4:28 PM ET

ABERCROMBIE GEORGE B 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 15, 2023

Insider Transaction Report

Form 4
Period: 2023-06-13
Transactions
  • Award

    Common Stock

    2023-06-13+16,74529,611 total
  • Award

    Automatic Stock Option Grant

    2023-06-13+39,07239,072 total
    Exercise: $8.18From: 2024-06-13Exp: 2033-06-13Common Stock (39,072 underlying)
Footnotes (2)
  • [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
  • [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT